A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy
- PMID: 18242539
- DOI: 10.1016/j.hrthm.2007.09.027
A prospective, multicenter evaluation of ablating complex fractionated electrograms (CFEs) during atrial fibrillation (AF) identified by an automated mapping algorithm: acute effects on AF and efficacy as an adjuvant strategy
Abstract
Background: Complex fractionated electrograms (CFEs) are continuous electrograms (EGMs) of very short cycle length (CL) representing substrate for atrial fibrillation (AF) perpetuation. Ablation of CFEs may result in AF slowing, termination, and prevention, but identifying them can be subjective.
Objective: The purpose of this study was to prospectively assess (1) whether an automated algorithm can identify CFE regions, (2) the acute effects of ablating these regions on AF, and (3) the long-term efficacy as an adjuvant strategy to pulmonary vein antrum isolation (PVAI).
Methods: Thirty-five patients (three centers, 61 +/- 9 years, left atrium [LA] 43 +/- 9 mm, ejection fraction 53% +/- 7%) with symptomatic paroxysmal (n = 21) or persistent (n = 14) AF were studied. A decapolar lasso (2-mm spacing) was used for mapping. A three-dimensional shell of the LA and pulmonary veins (PVs) was created. If not already in AF, AF was induced by burst pacing (with or without isoproterenol). Atrial EGMs during AF were mapped/analyzed using an automated CFE algorithm. The algorithm measures the time between discrete deflections in a local EGM over 5 seconds (based on selectable width and peak-to-peak [>0.03 mV] criteria). The mean CL of the local EGM is projected onto the LA shell as a color-coded display. Regions of CL <120 ms (published criteria) were targeted for ablation/elimination. Atrial fibrillation cycle length (AFCL) and regularity were measured from the CS. After CFE ablation, further ablation was done to achieve complete PVAI.
Results: AF was spontaneous (n = 20) or induced (n = 15) in all patients. CFEs were most commonly found along the septum (97%), anterior LA (97%), PV antra (83%), base of appendage (83%), and annulus (71%). CFE ablation alone prolonged the AFCL (171 +/- 27 vs. 304 +/- 41 ms; P = .03) and regularized AF to left/right flutter (AFL) in 74% of patients. CFE ablation terminated AF/AFL in 19 patients (54%)-the other 16 were cardioverted-and AF became noninducible in 77%. CFE ablation alone did not cause PV isolation (0.1 +/- 0.3 PV isolated/patient). After combined CFE and PVAI ablation, the single-procedure, off-drug success rate was 83% (follow-up 13 +/- 4 months) versus 71% in matched controls who had PVAI alone (P = .045).
Conclusions: CFE ablation guided by an automated algorithm resulted in AFCL prolongation, regularization, and noninducibility in most patients. AF terminated in 54% of cases. PVAI with adjuvant CFE ablation has a high efficacy and may be superior to PVAI alone.
Comment in
-
Atrial fibrillation: when have we burned enough?Heart Rhythm. 2008 Feb;5(2):206-7. doi: 10.1016/j.hrthm.2007.10.034. Epub 2007 Oct 23. Heart Rhythm. 2008. PMID: 18242540 No abstract available.
Similar articles
-
Relationship between complex fractionated electrograms (CFE) and dominant frequency (DF) sites and prospective assessment of adding DF-guided ablation to pulmonary vein isolation in persistent atrial fibrillation (AF).J Cardiovasc Electrophysiol. 2011 Dec;22(12):1309-16. doi: 10.1111/j.1540-8167.2011.02128.x. Epub 2011 Jul 7. J Cardiovasc Electrophysiol. 2011. PMID: 21736659
-
Randomized comparison between pulmonary vein antral isolation versus complex fractionated electrogram ablation for paroxysmal atrial fibrillation.J Cardiovasc Electrophysiol. 2011 Sep;22(9):973-81. doi: 10.1111/j.1540-8167.2011.02051.x. Epub 2011 May 3. J Cardiovasc Electrophysiol. 2011. PMID: 21539635 Clinical Trial.
-
Efficacy of adjuvant anterior left atrial ablation during intracardiac echocardiography-guided pulmonary vein antrum isolation for atrial fibrillation.J Cardiovasc Electrophysiol. 2007 Feb;18(2):151-6. doi: 10.1111/j.1540-8167.2006.00673.x. J Cardiovasc Electrophysiol. 2007. PMID: 17338763 Clinical Trial.
-
[Interventional therapy of atrial fibrillation: possibilities and limitations].Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S48-54. doi: 10.1055/s-0030-1249209. Epub 2010 Mar 10. Dtsch Med Wochenschr. 2010. PMID: 20221979 Review. German.
-
The stepwise ablation approach for chronic atrial fibrillation--evidence for a cumulative effect.J Interv Card Electrophysiol. 2006 Sep;16(3):153-67. doi: 10.1007/s10840-006-9045-1. Epub 2006 Nov 14. J Interv Card Electrophysiol. 2006. PMID: 17103313 Review.
Cited by
-
Long-term outcomes of adjunctive complex fractionated electrogram ablation to pulmonary vein isolation as treatment for non-paroxysmal atrial fibrillation.J Interv Card Electrophysiol. 2013 Oct;38(1):19-26. doi: 10.1007/s10840-013-9816-4. Epub 2013 Jul 7. J Interv Card Electrophysiol. 2013. PMID: 23832383 Clinical Trial.
-
Prediction of mid-term outcome after cryo-balloon ablation of atrial fibrillation using post-procedure high-sensitivity troponin level.Cardiovasc J Afr. 2015 Jul-Aug;26(4):165-70. doi: 10.5830/CVJA-2015-027. Epub 2015 Mar 17. Cardiovasc J Afr. 2015. PMID: 25783791 Free PMC article.
-
Electrogram Morphology Recurrence for Mapping Persistent Atrial Fibrillation: Initial vs Redo Catheter Ablation.JACC Clin Electrophysiol. 2023 Apr;9(4):526-540. doi: 10.1016/j.jacep.2022.11.003. Epub 2023 Jan 18. JACC Clin Electrophysiol. 2023. PMID: 36669899 Free PMC article.
-
Efficacy of adjunctive ablation of complex fractionated atrial electrograms and pulmonary vein isolation for the treatment of atrial fibrillation: a meta-analysis of randomized controlled trials.Europace. 2011 Feb;13(2):193-204. doi: 10.1093/europace/euq384. Epub 2010 Oct 30. Europace. 2011. PMID: 21037322 Free PMC article.
-
Ablation for Persistent Atrial Fibrillation-Is There a Role for More Than PVI?Curr Treat Options Cardiovasc Med. 2016 Mar;18(3):15. doi: 10.1007/s11936-016-0437-y. Curr Treat Options Cardiovasc Med. 2016. PMID: 26874703
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials